Result of Retail Offer
4basebio PLC has announced the successful closure of its Retail Offer, which, along with a Placing and Subscription, has conditionally raised approximately £15 million in gross proceeds. The Company will issue 6,891 new ordinary shares at an issue price of 515 pence per share, with admission of these shares expected on November 10, 2026. Following admission, the total issued share capital will be 19,234,728 Ordinary Shares.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
CAMBRIDGE, UK - 21 October 2026 - 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing for next-generation genomic medicines and advanced therapies, is pleased to announce that the Retail Offer launched on 15 October 2026 has now closed. Subject to the Retail Offer becoming unconditional, the Company will issue 6,891 new ordinary shares of €1.00 each in the capital of the Company (the "Retail Offer Shares") at an issue price of 515 pence per Retail Offer Share (the "Issue Price").
Following the close of the Retail Offer, the Company has conditionally raised aggregate gross proceeds of approximately £15 million through the Placing, Subscription, and Retail Offer (together, the "Capital Raise").
As set out in the announcement of the Retail Offer published on 15 October 2026, the Retail Offer is conditional, inter alia, upon the passing of the Resolutions by Shareholders at the General Meeting, completion of the Placing and Subscription, and the Retail Offer Shares to be issued pursuant to the Retail Offer being admitted to trading on the AIM market operated by the London Stock Exchange ("Admission"). The Placing and Subscription are not conditional upon completion of the Retail Offer. Admission of the Retail Offer Shares is expected to take place at 8.00 a.m. on 10 November 2026.
Subject to Admission, the Company will issue and allot a total of 3,696,210 New Shares pursuant to the Placing, Subscription and Retail Offer. The issued share capital of the Company following Admission will comprise 19,234,728 Ordinary Shares. A separate announcement will be made following the General Meeting of the results of the General Meeting and the total voting rights following Admission.
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the announcement of the Capital Raise made by the Company at 7.00 a.m. on 15 October 2026.
UK Product Governance Requirements
EU Product Governance Requirements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.